A New Era for Cell Therapy The landscape of oncology treatment is shifting. Typewriter Therapeutics has officially emerged from stealth mode, announcing a significant $56 million Series A financing round. This milestone marks a bold step forward in the development of in vivo CAR-T medicines, aiming to make advanced cell therapies more accessible and effective.…